Navigation Links
FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight
Date:6/8/2009

ote&Ticker=HGSI'> HGSI)

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense competition, the uncertainty of patent and intellectual property protection, the Company's dependence on key management and key suppliers, the uncertainty of regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, while the Company has completed shipment of ABthrax to the U.S. Strategic National Stockpile, the Company will continue to face risks related to FDA's approval of the Company's Biologics License Application for ABthrax. If the Company is unable to meet requirements associated with the ABthrax contract, future revenues from the sale of ABthrax to the U.S. Government will not occur. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences undertakes no obligation to update or revise the information contained in this announcement whether as a result of
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 2015  EnteroMedics Inc. (NASDAQ: ETRM ), a ... to treat obesity, metabolic diseases, and other gastrointestinal disorders, ... of its previously announced underwritten public offering of 40,229,886 ... per unit. Canaccord Genuity was acting ... acting as co-manager for the offering. The ...
(Date:7/6/2015)... -- EndoChoice Holdings, Inc. (NYSE:  GI) announced today that it ... Thursday, August 6, 2015 before the market open. ... Thursday, August 6, 2015 at 9:00 a.m. ET to ... for domestic callers and (412) 317-5415 for international callers.  ... available on the investor relations section of the Company,s ...
(Date:7/6/2015)... HAYWARD, Calif. , July 6, 2015  Impax ... the Company will release its second quarter 2015 financial ... open of the U.S. financial markets. The Company will ... investment community at 8:30 a.m., Eastern Time on August ... webcast will be accessible through the Investor Relations section ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Termination of Public Offering of Common Stock and Warrants 2EndoChoice to Report Second Quarter 2015 Financial Results on August 6, 2015 2Impax to Report Second Quarter 2015 Results on August 10, 2015 2
... 17, 2011 Experts from PAREXEL International Corporation (Nasdaq: ... provider, will address best-practice strategic partnership models to increase ... Annual Partnerships in Clinical Trials conference, to be held ... learn more about how PAREXEL has transformed ...
... 16, 2011 Amarin Corporation plc (Nasdaq: ... disease, today reported financial results for the fiscal year ... also provided an update on its progress with the ... AMR101 for the treatment of elevated triglyceride levels, which ...
Cached Medicine Technology:PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials 2PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials 3PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials 4Amarin Reports Year-End and Q4 2010 Results 2Amarin Reports Year-End and Q4 2010 Results 3Amarin Reports Year-End and Q4 2010 Results 4Amarin Reports Year-End and Q4 2010 Results 5Amarin Reports Year-End and Q4 2010 Results 6Amarin Reports Year-End and Q4 2010 Results 7Amarin Reports Year-End and Q4 2010 Results 8Amarin Reports Year-End and Q4 2010 Results 9
(Date:7/6/2015)... ... 06, 2015 , ... PristineHydro ( http://www.pristinewaterfilters.com ) has developed ... impurities; it also properly mineralizes the water with electrolyte salts.  Common tap water ... contaminants are a byproduct of how the water is treated chemically.  In response, ...
(Date:7/6/2015)... ... July 06, 2015 , ... “ TapGlance ” was featured on NewsWatch ... coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the host ... this interior design app helps users visualize what rooms will look like before they ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... University ... revising national guidelines for thyroid cancer testing to reflect newly available tests that better ... to use and how to interpret thyroid cancer tests is published in the July ...
(Date:7/6/2015)... ... July 06, 2015 , ... In order to recognize and ... Society for Sports Medicine ( AOSSM ) will present ten research awards and ... a leader in orthopaedic sports medicine, AOSSM annually provides more than $350,000 to ...
(Date:7/6/2015)... ... July 06, 2015 , ... On June 22, 2015, Fox News in a report titled “ Female Hair Loss ... turn age 35 a quarter of all women in the U.S. will suffer from thinning ... stigmatized and rarely discussed. One woman, a former beauty queen, who was interviewed for the ...
Breaking Medicine News(10 mins):Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 3Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 4Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 5Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 6Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2
... and treated in many cases, say US doctors. In peripheral ... become blocked with the same kind of fatty deposits - ... of treating it is very simple - keep walking. While ... the ability to walk with ease. Positive effects are seen ...
... Nearly half of people with Parkinson's disease are using one ... as vitamins, message or acupuncture. Researchers at Johns Hopkins University ... than 200 people with Parkinson's disease. Forty per cent use ... cent use five or more different ones. There's no link ...
... Bubonic plague, the bacterium blamed for the Black Death ... biological weapon, has had its entire genome sequenced. The ... and picking up new genes from other microbes. ,That ... emerge. More ominously, it suggests that enhanced strains might ...
... with a skin condition called contact dermatitis may benefit from ... tomatoes, according to the results of a small study.// Individuals ... they come in contact with substances they are allergic to. ... the skin, and many people may not realize foods can ...
... New research confirms that the main ingredient in the -- ... loss when used long term. The younger you are when ... bone-related problems later in life. // ... our bone mass is constantly breaking down and re-building, usually ...
... Suppression of testosterone levels in men with testicular ... disease, warn US researchers.,A research team from North ... levels go down, a high rise in levels ... disease – occurs. They suggest that this phenomenon ...
Cached Medicine News:Health News:Sequencing of the Plague 2
... Template is designed for use with ... for prostate brachytherapy. Please be sure ... match the graphics on the Reusable ... protruding from lower surface which fits ...
Table mount stabilizer system...
The compact PT stepper is lightweight, user-friendly, and versatile. The perfect solution for a busy brachytherapy facility....
... source consists of a welded titanium capsule ... four resin beads. The capsule body ... serve as x-ray markers to identify the ... are supplied non-sterile when shipped and must ...
Medicine Products: